Nikhil Narang, MD(@Nikhil15) 's Twitter Profileg
Nikhil Narang, MD

@Nikhil15

HF/Transplant/LVAD Cardiologist, Advocate Christ Medical Center @advocatehealth • @UCCardsfellows @MedChiefs alum • Dad • #JACCHF #SoMe Team @JACCJournals

ID:16662432

calendar_today09-10-2008 05:06:05

3,2K Tweets

2,7K Followers

1,5K Following

Follow People
Novi Tham(@slumberbell) 's Twitter Profile Photo

How to define stage⁉️

Dr and BiykemBozkurt proposed 3 categories to define this grey
area:

1️⃣Structural Heart Abnormalities
-🫀structural/functional issue w/o ⬆️ NPs
- e.g: LVH, chambers enlargements, wall motion abnormalities

2️⃣Heart Stress
-⬆️

How to define #PreHF stage⁉️ Dr #AntoniBayesGenis and @BiykemB proposed 3 categories to define this grey area: 1️⃣Structural Heart Abnormalities -🫀structural/functional issue w/o ⬆️ NPs - e.g: LVH, chambers enlargements, wall motion abnormalities 2️⃣Heart Stress -⬆️#Biomarkers…
account_circle
Munir S Janmohamed MD FACC, FHFSA(@MunirJanmohamed) 's Twitter Profile Photo

New in
⭐️Role of Palliative Care Across HF

Improves
⬆️ Sx Control
⬆️ QOL
⬆️ Caregiver satisfaction
⬇️ Caregiver Anxiety.

🔑 Limited Palliative care workforce
✅ Novel Palliative Care models are needed to met needs to improve care of HF pts JACC Journals

New in #jacchf ⭐️Role of Palliative Care Across HF Improves ⬆️ Sx Control ⬆️ QOL ⬆️ Caregiver satisfaction ⬇️ Caregiver Anxiety. 🔑 Limited Palliative care workforce ✅ Novel Palliative Care models are needed to met needs to improve care of HF pts @JACCJournals #JACCHF
account_circle
Muthu Vaduganathan(@mvaduganathan) 's Twitter Profile Photo

🚨 All-Generic Quadruple Therapy for HF on the Horizon 🚨

This week, U.S. FDA approved first generics of sacubitril/valsartan. Joins first approved generics of in ‘22. Still short while before these generics can be marketed

One step closer…
fda.gov/news-events/pr…

🚨 All-Generic Quadruple Therapy for HF on the Horizon 🚨 This week, @US_FDA approved first generics of #ARNI sacubitril/valsartan. Joins first approved generics of #SGLT2i in ‘22. Still short while before these generics can be marketed One step closer… fda.gov/news-events/pr…
account_circle
Sharmila Dorbala(@DorbalaSharmila) 's Twitter Profile Photo

Amazing presentation by Brett Sperry, MD detailing tafamidis long term data 1)Continued survival benefit in the longterm. 2) stabilized eGFR compared to placebo 3) reduced decline in health status and functional capacity in octogenarians 4) benefit in NYHA3

Amazing presentation by @BrettSperryMD detailing tafamidis long term data 1)Continued survival benefit in the longterm. 2) stabilized eGFR compared to placebo 3) reduced decline in health status and functional capacity in octogenarians 4) benefit in NYHA3
account_circle
Jon Grinstein MD(@JonGrinsteinMD) 's Twitter Profile Photo

Excited to share the results of PREDICT HF, a multi-center study examining the prognostic role of advanced hemodynamic parameters in heart failure. In summary, the simultaneous assessment of CPO (power) and API (efficiency) nicely risk stratifies patients onlinelibrary.wiley.com/doi/full/10.10…

account_circle
Nikhil Narang, MD(@Nikhil15) 's Twitter Profile Photo

Can novel smartphone applications using accelerometer + gyroscope measurements be used to detect HF?

Insight into the high accuracy algorithms using motion sensors from smartphones to detect HF 📱

REFLECS study now in JACC Journals

📎 jacc.org/doi/10.1016/j.…

Can novel smartphone applications using accelerometer + gyroscope measurements be used to detect HF? Insight into the high accuracy algorithms using motion sensors from smartphones to detect HF 📱 REFLECS study now in @JACCJournals #JACCHF 📎 jacc.org/doi/10.1016/j.…
account_circle
Anju Bhardwaj MD FACC(@docbhardwaj) 's Twitter Profile Photo

common with

Overlapping risk factors-obesity, HTN, aging, inflammation

⬆️ filling pressures, atrial remodeling from HFpEF ->AF
Dx allows therapy with ⬆️ outcomes

AF> 6 mins, needs OAC to ⬇️ CVA

👉 jacc.org/doi/10.1016/j.… JACC Journals
Yogesh Reddy et al

#AF common with #HFpEF Overlapping risk factors-obesity, HTN, aging, inflammation ⬆️ filling pressures, atrial remodeling from HFpEF ->AF Dx allows therapy with ⬆️ outcomes AF> 6 mins, needs OAC to ⬇️ CVA 👉 jacc.org/doi/10.1016/j.… @JACCJournals #JACCHF @yreddyhf et al
account_circle
Anju Bhardwaj MD FACC(@docbhardwaj) 's Twitter Profile Photo

SCAI stage C CS & <30% increase in PP ➕
persistently ⬆️ lactate ~ 24 hrs of initiation of inotropes, ( ⬆️ 🏥 mortality noted)
🎯 Evaluate for escalation of support

jacc.org/doi/full/10.10…
JACC Journals Benjamin Hibbert
Mark Belkin Jon Grinstein MD & team

SCAI stage C CS & <30% increase in PP ➕ persistently ⬆️ lactate ~ 24 hrs of initiation of inotropes, ( ⬆️ 🏥 mortality noted) 🎯 Evaluate for escalation of support jacc.org/doi/full/10.10… @JACCJournals #JACCHF @benhibbertMDPhD @MarkBelkinMD @JonGrinsteinMD & team
account_circle
Jacob Abraham, MD(@Abraham_Jacob) 's Twitter Profile Photo

A privilege to share lessons from trials of remote hemodynamic monitoring, Providence Oregon workflows, and a glimpse of future technologies with the Advocate HF team

Thanks Nikhil Narang, MD for the invitation

cc: Gregory Macaluso

account_circle